Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.02 – $0.10
7% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26.4M | $26.3M | $22.9M | $21.4M | $20.4M | $18.6M | $16.1M | $10.7M |
| Cost of revenue | $14.6M | $13.4M | $11.8M | $8.7M | $8.5M | $7.1M | $5.4M | $3.9M |
| Gross profit | $11.8M | $13.0M | $11.1M | $12.7M | $11.9M | $11.5M | $10.7M | $6.9M |
| Gross margin | 44.8% | 49.3% | 48.6% | 59.4% | 58.5% | 61.9% | 66.6% | 64.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $858.9K | −$2.0M | −$3.4M | −$1.0M | −$2.2M | −$815.0K | $383.8K | $721.4K |
| EBITDA | $916.7K | $3.8M | −$2.3M | −$1.2M | −$1.4M | $3.4M | $1.8M | $881.0K |
| Net income | $699.7K | $4.0M | −$3.3M | −$1.4M | −$1.6M | $3.1M | $1.5M | $514.0K |
| Net margin | 2.6% | 15.0% | -14.5% | -6.7% | -7.8% | 16.6% | 9.1% | 4.8% |
| EPS (diluted) | 0.04 | 0.05 | -0.05 | -0.02 | -0.02 | 0.04 | 0.02 | 0.01 |
Annual figures · source: Financial Modeling Prep
FUSE MEDICAL INC
No one on the platform currently holds FZMD.
No tracked institution reports a position in FZMD as of their last filing.
No one on the platform has traded FZMD yet.
| $6M |
| — |
| RMSLREMSleep Holdings, Inc. | $0.00 | -4.17% | $4M | — |
| RNVARennova Health, Inc. | $0.00 | +0.00% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at NaN× earnings vs its 7.0× historical median P/E.
Fair value ≈ $-0.17 · price $0.02 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.